Willem-Alexander Children's Hospital, Department of Pediatrics and Laboratory for Pediatric Immunology, Leiden University Medical Center, Leiden, Netherlands.
Front Immunol. 2019 Apr 12;10:782. doi: 10.3389/fimmu.2019.00782. eCollection 2019.
B cell reconstitution after hematopoietic stem cell transplantation (HSCT) is variable and influenced by different patient, donor, and treatment related factors. In this review we describe B cell reconstitution after pediatric allogeneic HST, including the kinetics of reconstitution of the different B cell subsets and the development of the B cell repertoire, and discuss the influencing factors. Observational studies show important roles for stem cell source, conditioning regimen, and graft vs. host disease in B cell reconstitution. In addition, B cell recovery can play an important role in post-transplant infections and vaccine responses to encapsulated bacteria, such as pneumococcus. A substantial number of patients experience impaired B cell function and/or dependency on Ig substitution after allogeneic HSCT. The underlying mechanisms are largely unresolved. The integrated aspects of B cell recovery after HSCT, especially BCR repertoire reconstitution, are awaiting further investigation using modern techniques in order to gain more insight into B cell reconstitution and to develop strategies to improve humoral immunity after allogeneic HSCT.
造血干细胞移植(HSCT)后 B 细胞的重建是可变的,并受不同患者、供体和治疗相关因素的影响。在这篇综述中,我们描述了儿科异基因 HSCT 后的 B 细胞重建,包括不同 B 细胞亚群重建的动力学和 B 细胞库的发展,并讨论了影响因素。观察性研究表明,干细胞来源、预处理方案和移植物抗宿主病在 B 细胞重建中起着重要作用。此外,B 细胞的恢复可以在移植后感染和对荚膜细菌(如肺炎球菌)的疫苗反应中发挥重要作用。相当多的患者在异基因 HSCT 后经历 B 细胞功能受损和/或依赖 Ig 替代治疗。其潜在机制在很大程度上仍未得到解决。为了更深入地了解 B 细胞重建,并制定改善异基因 HSCT 后体液免疫的策略,使用现代技术进一步研究 HSCT 后 B 细胞重建的综合方面,特别是 BCR 库的重建,是必要的。